HomeIMRX • NASDAQ
add
Immuneering Corp
Previous close
$1.43
Day range
$1.43 - $1.51
Year range
$1.40 - $11.92
Market cap
43.59M USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.30M | 16.56% |
Net income | -15.08M | -13.88% |
Net profit margin | — | — |
Earnings per share | -0.52 | -4.00% |
EBITDA | -16.20M | -16.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 85.67M | -18.82% |
Total assets | 102.58M | -16.17% |
Total liabilities | 12.01M | -4.06% |
Total equity | 90.58M | — |
Shares outstanding | 29.28M | — |
Price to book | 0.46 | — |
Return on assets | -37.65% | — |
Return on capital | -40.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.08M | -13.88% |
Cash from operations | -11.78M | -0.23% |
Cash from investing | 3.13M | -61.57% |
Cash from financing | 7.84K | 104.24% |
Net change in cash | -8.63M | -128.37% |
Free cash flow | -6.47M | 5.12% |
About
Founded
2008
Website
Employees
68